<DOC>
	<DOC>NCT01159925</DOC>
	<brief_summary>The purpose of this study is to collect epidemiological and clinical data to assess the vaccine impact and occurrence of confirmed acute hepatitis A cases in sentinel hospitals after the introduction of Havrixâ„¢ into the Expanded Program of Immunization.</brief_summary>
	<brief_title>Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children</brief_title>
	<detailed_description>This is an observational, prospective, multi-centre, sentinel based study in 3 hospitals in Panama. Hospitals are selected based on population density or hepatitis A disease burden. The Pan American Health Organization (PAHO) definition for a possible case of acute hepatitis A are used for subjects aged between &gt;1 month and &lt;15 years. Data regarding clinical and epidemiologic information are collected and serum samples are collected to test hepatitis A markers and determine if infection with hepatitis A virus has recently occurred. Surveillance will be for a period of approximately 2.5 years from the date of study initiation.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<criteria>A male or female between &gt;1 month and &lt;15 years of age at the time of enrolment, being referred to any of the 3 participating sentinel hospitals. Subjects with clinical diagnosis of possible acute hepatitis A. Written informed consent obtained from the parent or guardian of the subject. Subjects for whom a blood sample is collected. Subjects with confirmed diagnosis of nonviral hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>